The Office of Inspector General, part of the US Department of Health and Human Services, has accused the Centers for Medicare and Medicaid Services (CMS) of failing to perform required audits of payments under the Part D prescription drug benefit for seniors. As a result of this alleged lapse in 2006, an estimated $4.4 billion was overcharged by about 80% of plan providers.
The damning report follows another by the Government Accountability Office, which noted that profits for insurers were $1.3 billion above expectations, although this was explained by deeper than expected discounts for prescription medicines negotiated by prescription benefit managers (Marketletter January 5 & 12).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze